Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Marando, C"'
Autor:
Patel MR; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, FL. Electronic address: mpatel@flcancer.com., Donnellan W; Tennessee Oncology, PLLC, Chattanooga, TN., Byrne M; Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN., Asch AS; Stephenson Cancer Center, Oklahoma University, Oklahoma City, OK., Zeidan AM; Yale University and Yale Cancer Center, New Haven, CT., Baer MR; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD., Fathi AT; Massachusetts General Hospital, Harvard Medical School, Boston, MA., Kuykendall AT; Moffitt Cancer Center, FL., Zheng F; Incyte Corporation, Wilmington, DE., Walker C; Incyte Corporation, Wilmington, DE., Cheng L; Incyte Corporation, Wilmington, DE., Marando C; Incyte Corporation, Wilmington, DE., Savona MR; Division of Hematology/Oncology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2023 Sep; Vol. 23 (9), pp. 674-686. Date of Electronic Publication: 2023 May 15.
Autor:
Koblish H; Incyte Corporation, Wilmington, Delaware, United States of America., Li YL; Incyte Corporation, Wilmington, Delaware, United States of America., Shin N; Incyte Corporation, Wilmington, Delaware, United States of America., Hall L; Incyte Corporation, Wilmington, Delaware, United States of America., Wang Q; Incyte Corporation, Wilmington, Delaware, United States of America., Wang K; Incyte Corporation, Wilmington, Delaware, United States of America., Covington M; Incyte Corporation, Wilmington, Delaware, United States of America., Marando C; Incyte Corporation, Wilmington, Delaware, United States of America., Bowman K; Incyte Corporation, Wilmington, Delaware, United States of America., Boer J; Incyte Corporation, Wilmington, Delaware, United States of America., Burke K; Incyte Corporation, Wilmington, Delaware, United States of America., Wynn R; Incyte Corporation, Wilmington, Delaware, United States of America., Margulis A; Incyte Corporation, Wilmington, Delaware, United States of America., Reuther GW; Department of Molecular Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida, United States of America., Lambert QT; Department of Molecular Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida, United States of America., Dostalik Roman V; Incyte Corporation, Wilmington, Delaware, United States of America., Zhang K; Incyte Corporation, Wilmington, Delaware, United States of America., Feng H; Incyte Corporation, Wilmington, Delaware, United States of America., Xue CB; Incyte Corporation, Wilmington, Delaware, United States of America., Diamond S; Incyte Corporation, Wilmington, Delaware, United States of America., Hollis G; Incyte Corporation, Wilmington, Delaware, United States of America., Yeleswaram S; Incyte Corporation, Wilmington, Delaware, United States of America., Yao W; Incyte Corporation, Wilmington, Delaware, United States of America., Huber R; Incyte Corporation, Wilmington, Delaware, United States of America., Vaddi K; Incyte Corporation, Wilmington, Delaware, United States of America., Scherle P; Incyte Corporation, Wilmington, Delaware, United States of America.
Publikováno v:
PloS one [PLoS One] 2018 Jun 21; Vol. 13 (6), pp. e0199108. Date of Electronic Publication: 2018 Jun 21 (Print Publication: 2018).